Cargando…

Novel targets for drug discovery in celiac disease

Celiac disease is a lifelong, immunological disorder induced by dietary protein-gluten, in a genetically susceptible populations, resulting in different clinical manifestations, the release of antibodies, and damage to the intestinal mucosa. The only recommended therapy for the disease is to strictl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Rahul Soloman, Singh, Ashutosh, Batra, Gitika, Kaur, Hardeep, Medhi, Bikash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Potential Pharmacological Targets
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892008/ https://www.ncbi.nlm.nih.gov/pubmed/31831931 http://dx.doi.org/10.4103/ijp.IJP_679_19

Ejemplares similares

Novel therapeutic targets for amyotrophic lateral sclerosis
por: Batra, Gitika, et al.
Publicado: (2019)

Newer potential pharmacological targets for autism spectrum disorder
por: Jain, R. Ashish, et al.
Publicado: (2019)

Target/therapies for chronic recurrent erythema nodosum leprosum
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV
por: Singh, Ashutosh, et al.
Publicado: (2020)

Integrative omics – An arsenal for drug discovery
por: Singh, Rahul Soloman, et al.
Publicado: (2022)

Update on the target structures of SARS-CoV-2: A systematic review
por: Prajapat, Manisha, et al.
Publicado: (2020)

A comprehensive insight on the challenges for COVID-19 vaccine: A lesson learnt from other viral vaccines
por: Singh, Rahul Soloman, et al.
Publicado: (2023)

Ethics of Clinical Science in a Public Health Emergency: Drug Discovery at the Bedside
por: Edwards, Sarah J. L.
Publicado: (2013)

Indirect Decompression Failure After Lateral Lumbar Interbody Fusion—Reported Failures and Predictive Factors: Systematic Review
por: Kirnaz, Sertac, et al.
Publicado: (2020)

Editorial: Novel therapeutic target and drug discovery for neurological diseases
por: Zhao, Kaiyue, et al.
Publicado: (2022)

Translational neuroscience: the state of the nation (a PhD student perspective)
por: Davies, Caitlin, et al.
Publicado: (2020)

Conferences in the time of COVID: notes on organizing and delivering the first Brain Conference
por: Li, Lucia M, et al.
Publicado: (2021)

Gender representation in science publication: evidence from Brain Communications
por: Marescotti, Manuela, et al.
Publicado: (2022)

Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome
por: Di Domenico, Fabio, et al.
Publicado: (2019)

15-Keto prostaglandin E(2) suppresses STAT3 signaling and inhibits breast cancer cell growth and progression
por: Lee, Eun Ji, et al.
Publicado: (2019)

Structural-Based Virtual Screening of FDA-Approved Drugs Repository for NSP16 Inhibitors, Essential for SARS-COV-2 Invasion Into Host Cells: Elucidation From MM/PBSA Calculation
por: Kumar, Subodh, et al.
Publicado: (2023)

Development in Assay Methods for in Vitro Antimalarial Drug Efficacy Testing: A Systematic Review
por: Sinha, Shweta, et al.
Publicado: (2017)

Editorial: Phytochemical-based nanoformulations to tackle drug resistance in cancer
por: Tuli, Hardeep Singh, et al.
Publicado: (2023)

Just Policy? An Ethical Analysis of Early Intervention Policy Guidance
por: Mortimer, Rose, et al.
Publicado: (2018)

Design Bioethics: A Theoretical Framework and Argument for Innovation in Bioethics Research
por: Pavarini, Gabriela, et al.
Publicado: (2021)

Targeting immunometabolism to treat COVID-19
por: O’Carroll, Shane M, et al.
Publicado: (2021)

Immuno-antibiotics: targeting microbial metabolic pathways sensed by unconventional T cells
por: Eberl, Matthias, et al.
Publicado: (2021)

Just How Cognitive Is “Cognitive Enhancement”? On the Significance of Emotions in University Students' Experiences with Study Drugs
por: Vrecko, Scott
Publicado: (2013)

Editor’s Note: Relates to: ‘Immuno-antibiotics: targeting microbial metabolic pathways sensed by unconventional T cells’
por: Eberl, Matthias, et al.
Publicado: (2021)

Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases
por: Zhang, Rui, et al.
Publicado: (2020)

New Hypoglycemic Drugs: Combination Drugs and Targets Discovery
por: Ni, Xiayun, et al.
Publicado: (2022)

Comparative cone-beam computed tomography evaluation of temporomandibular joint position and morphology in female patients with skeletal class II malocclusion
por: Lin, Min, et al.
Publicado: (2019)

The efficacy and safety of Botulinum Toxin Type A in painful knee osteoarthritis: a systematic review and meta-analysis
por: Zhai, Shuchao, et al.
Publicado: (2019)

Current status of in silico, preclinical and clinical study registries across the globe: A systematic review and meta-analysis
por: Kaur, Hardeep, et al.
Publicado: (2021)

Novel therapeutic approaches toward Hantaan virus and its clinical features’ similarity with COVID-19
por: Singh, Harvinder, et al.
Publicado: (2020)

Therapeutic Applications of Human and Bovine Colostrum in the Treatment of Gastrointestinal Diseases and Distinctive Cancer Types: The Current Evidence
por: Bagwe-Parab, Siddhi, et al.
Publicado: (2020)

Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development
por: Biber, Knut, et al.
Publicado: (2019)

Synthetic Biology Speeds Up Drug Target Discovery
por: Xie, Yixuan, et al.
Publicado: (2020)

Target-specific compound selectivity for multi-target drug discovery and repurposing
por: Wang, Tianduanyi, et al.
Publicado: (2022)

Systematic review and meta-analysis of effectiveness and safety of favipiravir in the management of novel coronavirus (COVID-19) patients
por: Prakash, Ajay, et al.
Publicado: (2020)

Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors “leflunomide” and “teriflunomide” in Covid-19: A narrative review
por: Kaur, Hardeep, et al.
Publicado: (2021)

Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach
por: Sarma, Phulen, et al.
Publicado: (2020)

The effect of a hybrid training program: Improving nursing communication skills and HCAHPS scores
por: Briggs, Kelly, et al.
Publicado: (2018)

Editorial: New Paradigms in Neuroscience and Related Targets for Drug Discovery
por: Salomone, Salvatore
Publicado: (2020)

Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification
por: Gunosewoyo, Hendra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mf87ov36mi224cncfip5a4n5qo